Markus Haeberlein
Executive Vice President, Discovery Science
Professional Overview
Markus Haeberlein is an accomplished pharmaceutical executive with over 20 years of experience in drug discovery and development. As the Executive Vice President of Discovery Science at Parabilis Medicines, he leads a team of scientists in the research and advancement of novel therapeutics for complex diseases. Recognized for his technical expertise and strategic leadership, Markus has spearheaded innovative discovery programs that have yielded promising drug candidates across diverse therapy areas.
Experience Summary
Current Role
As the Executive Vice President of Discovery Science at Parabilis Medicines, Markus is responsible for overseeing all aspects of the company's discovery research efforts. He leads a team of cross-functional scientists in the identification and validation of novel drug targets, as well as the design, synthesis, and optimization of potential drug candidates. Under his guidance, Parabilis has expanded its pipeline and advanced multiple programs into clinical development, positioning the company as a leader in the discovery of transformative therapies.
Career Progression
Prior to joining Parabilis, Markus held various leadership roles at Alkermes, where he built and directed the company's research organization. As the Senior Vice President and Head of Research, he was instrumental in driving the development of Alkermes' portfolio, including the successful advancement of several product candidates into late-stage clinical trials. Earlier in his career, Markus served as the Senior Vice President and Chief Scientific Officer at Proteostasis Therapeutics, where he led the discovery and preclinical development of novel small molecules targeting protein homeostasis pathways. He also held positions of increasing responsibility at AstraZeneca, where he made significant contributions to the company's medicinal chemistry and drug discovery capabilities.
Academic Background
Markus holds a Ph.D. in Organic Chemistry from the University of Freiburg in Germany, where he specialized in the design and synthesis of complex natural products. He has published numerous peer-reviewed articles and is an inventor on several patents, reflecting his deep scientific expertise and innovative approach to drug discovery.
Areas of Expertise
- Drug discovery and early-stage development
- Medicinal chemistry and small molecule optimization
- Protein homeostasis and cell biology
- Translational research and biomarker development
- Building and leading high-performing research teams
- Strategic planning and portfolio management
Professional Impact
Throughout his career, Markus has played a pivotal role in advancing the discovery and development of innovative therapies. At Parabilis, he has spearheaded the expansion of the company's discovery pipeline, leading to the progression of multiple drug candidates into clinical trials. His contributions have been recognized by his peers, and he is a sought-after speaker at industry conferences and events.
Conclusion
With his exceptional scientific expertise, proven track record of leadership, and unwavering commitment to advancing the field of drug discovery, Markus Haeberlein is poised to drive continued innovation and success at Parabilis Medicines. His deep understanding of the pharmaceutical industry and his ability to build and lead high-performing teams make him a valuable asset in the company's pursuit of transformative therapies for patients.
